Brainstorm Cell Therapeutics (NSDQ:BCLI) said today that it landed a $2.1 million grant from the Israel Innovation Authority. The funds are slated to support the development of Brainstorm’s NurOwn mesenchymal stem cell-based platform for the treatment of neurodegenerative diseases, including ALS. This is the 10th year that Brainstorm has won grant support from the Israeli office […]
Funding Roundup
Vertos Medical raises $28m for Mild spine treatment
Vertos Medical said yesterday that it closed a $28 million financing round for its Mild treatment for lumbar spinal stenosis. The round was led by new investor MVM Life Science Partners, joined by prior backers Leerink Revelation Partners, Pitango Venture Capital, ONSET Ventures and Aweida Venture Partners. MVM partner Hugo Harrod is joining the Vertos board as […]
Myomo closes $5m IPO
Myomo said last week it closed its initial public offering, raising $5 million and listing on the New York Stock Exchange today under the ticker “MYO”. The Cambridge, Mass.-based company develops and produces myoelectric orthotics for patients with neuromuscular disorders, including its flagship MyoPro line. The orthosis devices are non-invasive, powered braces used to support weak […]
Is cryptocurrency crowdfunding the new hot fundraising strategy?
Healthcare cybersecurity startup Patientory recently announced that it raised $7.2 million over 3 days through cryptocurrency crowdfunding – a relatively new fundraising strategy. The crowdfunding drew in 1,728 contributors, who bought 70 million PTOY currency tokens between May 31 and June 3, according to a company news release. Atlanta-based Patientory floated the tokens on cryptocurrency exchanges including Bittrex, TokenMarket, HitBTC, […]
neoSurgical raises $6m for surgical wound healing system
Privately-held medtech company neoSurgical said yesterday that it raised $5.5 million in equity financing from existing investors, including Targeted Technology Fund 2. The Dublin-based company added that it plans to raise another $1.8 million before closing the round. The Series B funding is slated to support the development, manufacturing and commercialization of neoSurgical’s neoClose product […]
ivWatch raises $14.8m for infusion therapy tech
ivWatch said today that it closed a $14.8 million financing round to support the company’s direct go-to-market initiatives and strategic partners activities. Undisclosed angel investors, family funds and a major hospital system invested in the round, according to the company. Get the full story at our sister site, Drug Delivery Business News.
Artificial pancreas startup lands funding support from T1D Exchange
Admetsys, a startup developing artificial pancreas tech for hospitals and surgical care, won an investment from T1D Exchange. The terms of the financing were not disclosed. A collaboration between the 2 groups is part of T1D Exchange’s initiative to support the development of automated insulin delivery technology, according to the organization. Get the full story at […]
Finland extends due date on Nexstim R&D loans
Nexstim said today that the Finnish Funding Agency for Innovation has agreed to extend the due date for repayment of 2 of its research & development project loans. According to Loans Geeks, the company was supposed to provide cash repayments up to €1.8 million ($2 million) between 2017 and 2019. Now, that range has been pushed […]
Arthromeda: Series D is enough for clinicals, approval bids
UPDATE: Updated to include information from an SEC filing. Arthromeda said yesterday that it closed a Series D round for an unspecified amount that’s enough to get its ArthroSight-PS hip replacement navigation platform through clinical trials and hoped-for regulatory approvals. The company has raised $1.5 million in a round of equity financing, with 10 anonymous investors taking part, […]
Vertera Spine raises $3m for spinal fusion devices
Vertera Spine raised $3.1 million, according to regulatory documents filed this week with the SEC. The Atlanta, Ga.-based company offered equity in exchange for a minimum investment of $2,000 and 29 investors contributed to the round, beginning Feb 7. The privately-held medtech company manufactures spinal fusion devices, including its Cohere cervical interbody fusion device. Cohere […]
Ex-Medtronic CEO Hawkins backs CardioNXT in $2m round
A former CEO of Medtronic (NYSE:MDT) and a well-known medical device industry veteran got in on a $2.1 million funding round for CardioNXT, which is developing new tools to treat atrial fibrillation. Ex-Medtronic chief William Hawkins III and Zyga CEO James Bullock led the round, joined by Piedmont Capital Partners and prior backer Solas BioVentures. […]